DEXCOM INC. DL-,001/ US2521311074 /
2024-05-17 5:45:20 PM | Chg. +1.98 | Volume | Bid8:59:15 PM | Ask8:59:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
120.82EUR | +1.67% | 30 Turnover: 3,624.60 |
120.16Bid Size: 340 | 120.46Ask Size: 340 | 47.72 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.